NEW YORK: Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the world’s biggest pharmaceuticals companies.

Plans for the fund, the first of its kind, have been announced by Jeremy Hunt, the UK’s Read More »

SAN FRANCISCO: According to a research report on Global Deep Brain Stimulators (DBS) Market, published by Grand View Research, increasing incidence rates of target neurological disorders such as Parkinson’s and demand for minimally invasive surgical procedures are some primary factors expected to drive the deep Read More »

BALTIMORE: A recent study of retired football players by Johns Hopkins medical researchers adds to growing evidence linking football with brain damage.

The study focused on nine retired football players, but the results add to a growing body of research and anecdotal accounts associating brain Read More »

COLUMBUS: Research from the University of Leeds, UK, reports that resveratrol, a chemical found in red wine, may halt Alzheimer’s disease progression.

Initial findings were produced in an early-stage laboratory setting but they pave the way for further investigation in this area. This latest research Read More »